N ormal cellular functions essentially depend on a balanced redox environment. Free radicals and nonradical oxidants can shift the redox balance toward a more "oxidized" state, which is counteracted by the intracellular antioxidant defense systems. These include the enzymes superoxide dismutase and catalase, as well as the thiol-reducing systems (glutathione, glutaredoxin, and thioredoxin). Glutathione is the most abundant intracellular low molecular weight thiol existing predominantly in the thiol-reduced form (GSH), whereas the disulfide-oxidized form (GSSG) represents Ͻ2%. Glutathione regulates numerous cellular functions; GSH as an antioxidant reduces hydrogen peroxide and peroxynitrite directly and indirectly with the help of glutathione peroxidase, detoxifies electrophiles, modulates the reversible oxidation and reduction of protein thiols, and is critically involved in the regulation of enzymes, transcription factors, and signal transduction. 1 Loss of glutathione or disturbance of the GSH/GSSG redox potential causes cellular dysfunction. Multiple diseases, including cardiovascular diseases, are associated with the depletion of glutathione and a shift toward more oxidized GSH/GSSG redox potential. Restoring the GSH levels by substituting the glutathione precursor N-acetylcysteine or overexpressing glutathione peroxidase prevents cardiac dysfunction. 2, 3 However, little is known about the consequences of a more reductive redox state for cardiac function. Rajasekaran et al 4 first reported about "reductive stress" in mice expressing the human mutant ␣B-crystallin protein. These mice developed enhanced activity of glucose-6-phosphate dehydrogenase with increased production of NADPH and higher levels of GSH resulting in protein aggregation and cardiomyopathy. The human mutant ␣B-crystallin protein further induced expression of heat shock proteins (Hsps), in particular, Hsp25, and glutathione peroxidase, and decreased myocardial levels of reactive oxygen species. Hsps are upregulated under oxidative stress and protect against reactive oxygen species; they have also been implicated to influence glutathione metabolism. 5, 6 In the present issue of Hypertension, Zhang et al 7 report that cardiomyocyte-specific overexpression of Hsp27 induces reductive stress in the heart. In particular, mice expressing high levels of Hsp27 displayed increased myocardial glutathione peroxidase expression and activity, GSH, and GSH/ GSSG ratio and decreased reactive oxygen species levels, resulting in cardiac hypertrophy, dysfunction, and reduced lifespan (Figure) . Elevated GSH and glutathione peroxidase activity decrease levels of reactive oxygen species and might alter S-glutathionylation of several enzymes, transcription factors, and signaling proteins. By partly inhibiting glutathiThe opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.
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In contrast to the current concept of Hsp induction as a protective mechanism against oxidative stress, Zhang et al 7 demonstrate for the first time that high levels of Hsp27 by increasing GSH and GSH-peroxidase induce cardiomyopathy, suggesting that also in this case too much of a good thing may be bad. These data further strengthen the novel concept of reductive stress in the heart as a potential contributor to heart failure development and progression.
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